Agile Therapeutics
AGRX
$0.40
Share price
0.00%
Change (1 day)
-93.94%
Change (1 year)
Categories
EPS for Agile Therapeutics (AGRX)
EPS in 2023 (TTM): -$39.56
According to Agile Therapeutics 's latest financial reports the company's current EPS (TTM) is -$39.56. In 2022 the company made an earnings per share (EPS) of -$255.47 an increase over its 2021 EPS that were of -$1,560.
EPS history for Agile Therapeutics from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$39.56 | -84.51% |
| 2022 | -$255.47 | -83.62% |
| 2021 | -$1,560 | 30% |
| 2020 | -$1,200 | 53.85% |
| 2019 | -$780.00 | -32.76% |
| 2018 | -$1,160 | -36.26% |
| 2017 | -$1,820 | -9.9% |
| 2016 | -$2,020 | -26.28% |
| 2015 | -$2,740 | 21.79% |
| 2014 | -$2,250 | -29.13% |
| 2013 | -$3,175 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -135.60% | 🇺🇸 USA |
 Pfizer PFE | $1.86 | -104.70% | 🇺🇸 USA |
 Merck MRK | $1.82 | -104.60% | 🇺🇸 USA |
 TherapeuticsMD TXMD | $4.81 | -112.16% | 🇺🇸 USA |
 Antares Pharma ATRS | $0.34 | -100.86% | 🇺🇸 USA |